Back to News
Market Impact: 0.18
Viome Partners with Japan's Ezaki Glico to Bring Precision Health Intelligence to Japan
Source: Business Wire
Healthcare & BiotechProduct LaunchesTechnology & Innovation
Viome and Ezaki Glico launched mRNA HEALTH TRACKER, described as Japan's first personalized health service using gut-bacteria mRNA analysis. The partnership expands consumer-facing microbiome-based health testing in Japan, but the announcement provides no financial terms, revenue outlook, or adoption metrics.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.45
More News
- What investors need to know about Alphabet's stock-busting earnings report
- Microsoft's Big Bets on AI Start to Pay Off
- Google's Gemini 4 Carbon looks like a diamond in the rough
- Microsoft’s strong quarter backs up its stock rebound. Here's our new price target
- Can Southeast Asia pitch itself as an ‘all-in-one’ chip hub?
- As Waymo expands overseas, it remains a niche cash-burning business